$CDLX

Cardlytics (CDLX) announced it will release Q3 2026 earnings on Nov. 5, 2026, after market close. The company provided no additional details or guidance changes. This is a standard earnings announcement.

Cardlytics (CDLX) partnered with Rove to offer card-linked rewards to Rove's members, allowing them to earn travel rewards through linked payment cards. Cardlytics processes $5.8T in annual transaction data and has delivered $1.2B in rewards since 2008. The partnership expands Cardlytics' platform into the travel rewards sector.

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement As previously disclosed in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026 (the “Q2 2026 Form 10-Q”), in connection with the acquisition of Bridg, Inc. (“Bridg”) by Cardlytics, Inc. (th

Cardlytics (CDLX) reported Q2 2026 results on an earnings call. Revenue was $36.9M, down 36% YoY, with billings $65.5M (-34%) and adjusted contribution $21.3M (-32%). Net loss was $14.9M. Q3 2026 guidance: billings $61M-$67M, revenue $34M-$39M, adjusted EBITDA $0M-$3M. Cash was $28M.

Cardlytics (CDLX) reported a Q2 loss of $14.9 million, or $2.58 per share. Adjusted for discontinued operations, the loss was $1.50 per share. Revenue was $36.9 million. For the quarter ending September, the company expects revenue of $34 million to $39 million.

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Contribution of $21.3 million ◦ Net Loss of $(14.9) million

Cardlytics (CDLX) shareholders recently approved a reverse stock split authorization, elected three Class II directors, and ratified Deloitte & Touche as the independent auditor. Despite advisory approval for executive pay, the company faces financial challenges highlighted by its "Neutral" rating from TipRanks' AI Analyst, Spark, due to weak financial performance and bearish technicals, partially offset by improving cash flow and operational progress.

Cardlytics (NASDAQ: CDLX) Chief Financial Officer David Thomas Evans recently purchased 200,000 shares of the company's common stock through open-market transactions. These purchases, totaling $129,000, occurred on May 15 and May 18, 2026, at weighted average prices of $0.649 and $0.633 per share, respectively. Following these transactions, Evans directly holds 317,930 shares of Cardlytics common stock.

Cardlytics Inc (CDLX) has recently experienced stock price pressure due to thin trading volumes and changing investor sentiment towards adtech and fintech hybrids. The company operates a digital advertising platform embedded in banking apps, using aggregated transaction data to offer targeted cash-back deals without personally identifiable information. Cardlytics' revenue is driven by advertising fees based on campaign performance and its partnerships with major financial institutions, positioning it as a key player at the intersection of fintech and adtech.

Cardlytics, Inc. announced an inducement grant of 272,000 restricted stock units to six new employees on April 29, 2026, under the Nasdaq Listing Rule 5635(c)(4). These grants are a material inducement to employment and will vest over approximately two years, subject to continuous service. The grants were made under the Cardlytics, Inc. 2022 Inducement Plan.